0.4098

0.24% +0.001

Akili Inc (AKLI)

Overview News Price History Option Chain Financials Discussions Forecast

Akili Inc stock is currently priced at $0.4098, with a 24-hour trading volume of 801.04K. It has seen a +0.24% increased in the last 24 hours and a +62.36% rose in the past month. The chart indicates a potential bullish trend, as the stock is above the $0.4011 pivot point. If it approaches the $0.4257 resistance level, significant changes may occur.

Previous Close:

$0.4088

Open:

$0.4

24h Volume:

801.04K

Market Cap:

$32.22M

Revenue:

$1.68M

Net Income/Loss:

$-59.49M

P/E Ratio:

3.2916

EPS:

0.1245

Net Cash Flow:

$-58.01M

1W Performance:

+67.27%

1M Performance:

+62.36%

6M Performance:

-4.70%

1Y Performance:

-74.39%

1D Range:

$0.40

$0.432

52W Range:

$0.1912

$1.67

Akili Inc Stock (AKLI) Company Profile

Name

Akili Inc

Sector

Healthcare (1223)

Industry

Health Information Services (61)

Phone

617 456 0597

Address

125 Broad Street, 5th Floor, Boston

Employee

109

Twitter

Next Earnings Date

Latest SEC Filings

AKLI's Discussions on Twitter

Akili Inc Stock (AKLI) Latest News

Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

Why MariaDB Shares Are Trading Higher By Around 100%; Here Are 20 Stocks Moving Premarket

Benzinga

Should You Sell Your Penny Stocks? 3 Tips for When to Sell

PennyStocks

Gold Moves Lower; Pilgrim's Pride Earnings Top Views

Benzinga

Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga

Crude Oil Gains 1%; US New Home Sales Increase In January

Benzinga

Akili Inc Stock (AKLI) Financials Data

Akili Inc (AKLI) Revenue 2024

AKLI reported a revenue (TTM) of $1.68 million for the quarter ending December 31, 2023, a +419.50% rise year-over-year.

Akili Inc (AKLI) Net Income 2024

AKLI net income (TTM) was -$59.49 million for the quarter ending December 31, 2023, a -647.02% decrease year-over-year.

Akili Inc (AKLI) Cash Flow 2024

AKLI recorded a free cash flow (TTM) of -$58.01 million for the quarter ending December 31, 2023, a +30.58% increase year-over-year.

Akili Inc (AKLI) Earnings per Share 2024

AKLI earnings per share (TTM) was -$0.7623 for the quarter ending December 31, 2023, a -456.42% decline year-over-year.

Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive dysfunction. The company provides EndeavorRx, a computer-based testing for cognitive dysfunction across several neurology and psychiatry indications, including attention-deficit hyperactivity disorder, depressive disorder, autism spectrum disorder, multiple sclerosis, and other neuroinflammatory diseases. It offers selective stimulus management engine design to target neutral system, such as focus, interference processing, and multitasking; body brain trainer for attention, impulsivity, working memory, and goal management; and spatial navigation engine for spatial navigation, memory, and planning and organization. The company is headquartered in Boston, Massachusetts.